Haleon plcHLNNYSE

Overview Intelligence Charts News Fundamentals Key Metrics Earnings Growth Financials Insiders

Latest News

businesswire.com

NEW parodontax Gum Strengthen & Protect Launches as a Daily Solution for Long-Term Gum Protection

WARREN, N.J.--(BUSINESS WIRE)--parodontax, the gum expert brand from Haleon, has launched NEW parodontax Gum Strengthen & Protect Toothpaste and Mouthwash with Hyaluronic Acid^, a daily oral care innovation formulated to strengthen the gum seal where gums and teeth meet for long-lasting gum protection*. As consumers increasingly embrace preventative health habits, gums remain one of the most overlooked foundations of overall health. According to the American Dental Association, research has.

businesswire.com

Haleon Strengthens Commitment to China as Consumers Focus on Better Everyday Health

SHANGHAI--(BUSINESS WIRE)-- #ConsumerHealth--Haleon, a consumer company that is solely focused on better everyday health, is investing £65 million in a new state-of-the-art oral health manufacturing site in Shanghai. The facility will support the expansion of its oral care portfolio – which includes the global brands Sensodyne and parodontax – into China's fast-growing tier 2 and tier 3 cities, where rising incomes, growing awareness of everyday health and a shift towards trusted, branded products are reshaping.

reuters.com

Haleon makes oral-health push in China as other Western brands falter

Haleon is stepping ‌up its Chinese expansion, pushing into second- and third-tier cities and tailoring its gum-health products to local tastes, aiming to succeed where many Western consumer brands have struggled.

reuters.com

Haleon makes oral-health push in China as other Western brands falter

Haleon is stepping up its Chinese expansion, pushing into second- ‌and third-tier cities and tailoring its gum-health products to local tastes, aiming to succeed where many Western consumer brands have struggled.

businesswire.com

Study in Nature Medicine Finds Taking Centrum Silver Daily May Slow Biological Aging

WARREN, N.J.--(BUSINESS WIRE)--A new ancillary study published in Nature Medicine shows that Centrum Silver may slow biological aging markers. The findings come from an analysis of data from a randomized clinical trial, the COcoa Supplement and Multivitamin Outcomes Study (COSMOS), designed to evaluate how daily multivitamin use may influence biological aging over time. Biological aging refers to how well the body is functioning at a cellular level and may add important information about health.

zacks.com

Haleon PLC Sponsored ADR (HLN) Moves to Buy: Rationale Behind the Upgrade

Haleon PLC Sponsored ADR (HLN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

proactiveinvestors.co.uk

Haleon's weaker sales make mid-term targets 'not look credible'

Haleon PLC faces a familiar market dilemma after solid profit delivery was overshadowed by weaker than expected sales growth and cautious guidance. Fourth quarter organic growth of 2.1% disappointed, said Deutsche Bank, with misses in EMEA, Latin America and Asia Pacific, while North America was still down 1.0% like for like.

seekingalpha.com

Haleon plc (HLN) Q4 2025 Earnings Call Prepared Remarks Transcript

seekingalpha.com

Haleon plc (HLN) Q4 2025 Earnings Call Transcript

proactiveinvestors.co.uk

Haleon shares fall 3.4% as revenue growth falls short of the company's own medium-term target

A weak cold and flu season and a cautious American consumer pushed organic growth to 3%, a full percentage point below the floor of what Haleon has promised investors Haleon PLC (LSE:HLN, NYSE:HLN) shares fell 3.4% to 392.1p on Wednesday after the consumer health group reported full-year organic revenue growth of 3%, missing the 4-6% medium-term range it has set as its benchmark and leaving investors to weigh whether the shortfall reflects bad luck or something more structural. Two factors drove the underperformance.

proactiveinvestors.com

Haleon shares fall 3.4% as revenue growth falls short of the company's own medium-term target

A weak cold and flu season and a cautious American consumer pushed organic growth to 3%, a full percentage point below the floor of what Haleon has promised...

proactiveinvestors.com

AFC geared and ready for a pivotal year

AFC Energy PLC (AIM:AFC, OTC:AFGYF, FRA:QC8) believes that 2026 will be the year its pipeline of hydrogen opportunities converts into contractual orders...

proactiveinvestors.co.uk

Haleon misses its own revenue target for the year as a mild winter and a cautious American consumer drag organic growth to 3%

The consumer health group behind Sensodyne and Panadol fell short of its 4-6% medium-term benchmark, but delivered double-digit profit growth and strong cash generation that management says keeps the longer-term case intact Haleon PLC (LSE:HLN, NYSE:HLN) ended 2025 below its own expectations on the measure that matters most to investors. Organic revenue growth of 3% for the full year came in a full percentage point below the floor of the 4-6% medium-term range the company set for itself, the result of two headwinds that converged in the second half and proved harder to offset than the business had anticipated.

reuters.com

UK's Haleon reports slower fourth-quarter organic revenue growth

British consumer healthcare group Haleon reported a slowdown in fourth‑quarter revenue growth on Wednesday, as a delayed flu season hit sales of its respiratory-health products.

defenseworld.net

Haleon plc (LON:HLN) Given Average Recommendation of “Moderate Buy” by Brokerages

Haleon plc (LON: HLN - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the six brokerages that are currently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and four have issued a buy recommendation on the company.

defenseworld.net

Cidel Asset Management Inc. Takes Position in Haleon PLC Sponsored ADR $HLN

Cidel Asset Management Inc. acquired a new position in Haleon PLC Sponsored ADR (NYSE: HLN) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 450,689 shares of the company's stock, valued at approximately $4,043,000. A number of other

defenseworld.net

ABC Arbitrage SA Increases Stake in Haleon PLC Sponsored ADR $HLN

ABC Arbitrage SA raised its holdings in shares of Haleon PLC Sponsored ADR (NYSE: HLN) by 159.4% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,727,350 shares of the company's stock after buying an additional 1,675,889 shares during the

businesswire.com

New Sensodyne Clinical Repair Toothpaste Launches with Breakthrough Formula for Rapid, Clinically Proven Sensitivity Relief

WARREN, N.J.--(BUSINESS WIRE)--The No. 1 dentist-recommended brand for sensitive teeth has launched Sensodyne Clinical Repair, its newest option for sensitive teeth, a toothpaste designed to address the root cause of tooth sensitivity. Based on data showing that 85% of people with sensitive teeth want solutions that repair sensitivity by addressing the root cause of their pain, Sensodyne developed Clinical Repair to go beyond temporary relief and actively repair sensitive areas of teeth with co.

defenseworld.net

Haleon PLC Sponsored ADR $HLN Shares Sold by Cambiar Investors LLC

Cambiar Investors LLC decreased its position in Haleon PLC Sponsored ADR (NYSE: HLN) by 94.9% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 66,003 shares of the company's stock after selling 1,229,351 shares during the period. Cambiar Investors LLC's

defenseworld.net

Haleon (NYSE:HLN) and Canopy Growth (NASDAQ:CGC) Head to Head Contrast

Canopy Growth (NASDAQ: CGC - Get Free Report) and Haleon (NYSE: HLN - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability. Profitability This table compares Canopy Growth and Haleon's net

Loading news...

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance